personalized medicine
PGx-Guided Dosing Can Lead to Faster Therapeutic Blood Levels of Antidepressants
A randomized controlled trial compared cytochrome P450 genotype-based dosing of tricyclic antidepressants to usual care among patients with depression.
MultiOmic Health Raises £5M in Seed Funding Extension Round
The UK precision therapeutics discovery startup will use the new funding for a proof of concept in diabetic kidney disease.
Initial findings from the country's 10-year National Precision Medicine program could yield genetic tests tailored to Asian populations within Singapore and abroad.
Guardant Health, Parker Institute for Cancer Immunotherapy Partner on Immunotherapy Study
The goal is to identify genomic and epigenomic biomarkers in patient blood samples from PICI’s RADIOHEAD study using the GuardantINFINITY assay.
Predictive Oncology Shares Validation Data at AACR on Machine Learning Drug Development Platform
Premium
At AACR, the company shared data showing that its PeDAL platform could identify which tumors would respond to which drugs faster than traditional screening can.
Feb 10, 2023
Nov 7, 2022